MAPK Signaling

Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
-
B1174 LGX818Target: RafSummary: RAF inhibitor,potent and selective -
B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: inhibitor of p38α-mediated MK2a phosphorylation -
B9010 AEG 3482Target: JNKSummary: inhibitor of Jun kinase (JNK)-dependent apoptosis -
A5801 BIX 02189Target: MEK|ERKSummary: Selective MEK5 inhibitor -
B1173 B-Raf inhibitor 1 dihydrochlorideSummary: B-Raf inhibitor,potent and selective -
B6921 SKF 86002 dihydrochlorideSummary: p38 MAP kinase inhibitor -
B7738 SR 35761 CitationTarget: JNKSummary: JNK3 inhibitor, potent and selective -
A5707 PD318088Target: MEKSummary: Allosteric MEK1/2 inhibitor, non-ATP competitive -
B6188 Pamapimod (R-1503, Ro4402257)Summary: p38 MAPK inhibitor -
B1172 B-Raf inhibitor 1Summary: Potent and selective B-Raf inhibitor
